Morpholine → HCID 76750917, compound
Reaction equation
[NH2:1][C:2]1[N:11]=[C:10]([CH3:12])[C:9]2[C:8](=[N:13][O:14][CH2:15][C:16]([OH:18])=O)[CH2:7][CH:6]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][C:20]=3[C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)[CH2:5][C:4]=2[N:3]=1.S(Cl)(Cl)=O.[NH:35]1[CH2:40][CH2:39][O:38][CH2:37][CH2:36]1.C(N(CC)CC)C>C(Cl)Cl>[N:35]1([C:16](=[O:18])[CH2:15][O:14][N:13]=[C:8]2[CH2:7][CH:6]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][C:20]=3[C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)[CH2:5][C:4]3[N:3]=[C:2]([NH2:1])[N:11]=[C:10]([CH3:12])[C:9]2=3)[CH2:40][CH2:39][O:38][CH2:37][CH2:36]1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared from (2-amino-7-biphenyl-2-yl-4-methyl-7,8-dihydro-6H-quinazolin-5-ylideneaminooxy)-acetic acid (compound 69) by treating with thionyl chloride followed by amidation using morpholine and triethylamine in DCM.
Sources & evidence
- ORD record
- ord-e5cba02108e84063979af4184a9bdc86
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08592430B2
Reaction notes
Loading…